Lurasidone and Fluvoxamine Combination in Eating Disorders with Comorbid Obsessive–Compulsive Disorder: Preliminary Evidence from an Observational Study
Medical Sciences · 2025
DOI: 10.3390/medsci14010008 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Medical Sciences, 2025. Verfasst von Francesco Monaco und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mental Health, ASL Salerno, 84127 Salerno, Italy. Hauptthemen laut MEDLINE: Obsessive-Compulsive Disorder, Fluvoxamine, Lurasidone Hydrochloride, Feeding and Eating Disorders. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Anorexia nervosa (AN) and obsessive–compulsive disorder (OCD) share core features of cognitive rigidity, anxiety, and altered reward processing. Pharmacological options remain limited, and combined modulation of serotonergic and dopaminergic systems may provide new therapeutic directions. This naturalistic study explored the combined use of lurasidone and fluvoxamine in individuals with restrictive AN (AN-r) and comorbid OCD.
Methods
Forty-five female inpatients with AN-r and OCD were followed for six months. Participants received either lurasidone + fluvoxamine (n = 14) or heterogeneous SSRI/antipsychotic regimens (n = 31). Primary outcomes were the Recovery Assessment Scale (RAS) and Body Uneasiness Test Global Severity Index (BUT-GSI). Secondary outcomes included the Eating Disorder Examination-Questionnaire (EDE-Q) and Eating Disorder Inventory-3 (EDI-3). Bayesian repeated-measures ANOVAs were conducted, reporting BF10, BFInclusion, and P(M│data) values, with multiple imputation applied to manage missing data.
Results
Analyses indicated time-related changes across primary outcomes (RAS and BUT-GSI), with moderate-to-strong evidence (BF10 = 4.2–18.6) supporting overall improvement during treatment. Secondary and exploratory measures showed weaker or inconsistent trends (BF10 < 3). No evidence emerged for group-by-time interactions exceeding anecdotal strength.
Conclusions
Within the constraints of this small, all-female inpatient cohort, the findings illustrate directional, time-related changes compatible with global rehabilitation effects rather than drug-specific efficacy. The study demonstrates the feasibility—and methodological challenges—of applying Bayesian longitudinal modeling to incomplete clinical datasets. Future randomized or adaptive trials incorporating objective endpoints and data-quality pipelines are warranted to test whether serotonergic–dopaminergic–σ-1 synergy provides genuine clinical benefit in the AN–OCD spectrum.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Mental Health, ASL Salerno, 84127 Salerno, Italy.
- European Biomedical Research Institute of Salerno (EBRIS), 84121 Salerno, Italy.
- Department of Humanities, Philosophy and Education, University of Salerno, 84084 Fisciano, Italy.
- Department of Human Sciences, Education and Sport, University of Pegaso, 80100 Naples, Italy.
- Psychiatric Unit, Department of Health Sciences, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy.
ORCID-Profile: Francesco Monaco, Annarita Vignapiano, Ernesta Panarello, Stefania Landi, Giuseppe Scarano, Luca Steardo, Mauro Cozzolino
Zitieren
APA
Monaco, F., Vignapiano, A., Panarello, E., Landi, S., Scarano, G., Celia, G., Corrivetti, G., Steardo, L., & Cozzolino, M. (2025). Lurasidone and Fluvoxamine Combination in Eating Disorders with Comorbid Obsessive–Compulsive Disorder: Preliminary Evidence from an Observational Study. Medical Sciences. https://doi.org/10.3390/medsci14010008
Vancouver
Monaco F, Vignapiano A, Panarello E, Landi S, Scarano G, Celia G, et al. Lurasidone and Fluvoxamine Combination in Eating Disorders with Comorbid Obsessive–Compulsive Disorder: Preliminary Evidence from an Observational Study. Medical Sciences. 2025. doi:10.3390/medsci14010008
BibTeX
@article{Monaco2025,
author = {Monaco, Francesco and Vignapiano, Annarita and Panarello, Ernesta and Landi, Stefania and Scarano, Giuseppe and Celia, Giovanna and Corrivetti, Giulio and Steardo, Luca and Cozzolino, Mauro},
title = {Lurasidone and Fluvoxamine Combination in Eating Disorders with Comorbid Obsessive–Compulsive Disorder: Preliminary Evidence from an Observational Study},
journal = {Medical Sciences},
year = {2025},
doi = {10.3390/medsci14010008}
}
EUVIMED